SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artículo

CRUZ CH, Rodrigo et al. Micosis pulmonares en pacientes de la Quinta Región: Período 2007-2010. Rev. méd. Chile [online]. 2012, vol.140, n.5, pp. 595-601. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872012000500006.

    1. Pitt JI. The current rol of Aspergillus and Penicillium in human and animal health. J Med Vet Mycol 1994; 32 (1): 17-32. [ Links ]

    2. Ascioglu S, Rex JH, De Pauw B, Bennett J E, Bille J, Crokaert F, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An International Consensus. Clin Infect Dis 2002; 34: 7-14. [ Links ]

    3. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999; 12: 310-5. [ Links ]

    4. Jarque I, Sanz M. Las infecciones fúngicas invasoras en el paciente oncohematológico. En: Pontón J, Quindós G, Editores, Micosis invasoras en los pacientes oncohematológicos. Guía de bolsillo. Sociedad Española de Micología 2009; p. 3-12. [ Links ]

    5. García-Ruiz JC, Amutio E, Ponton J. Infección fúngica invasora en pacientes inmunodeficientes. Rev Iberoam Micol 2004; 21: 55-62. [ Links ]

    6. Enoch DA, Ludlam HA and Brown NM. Invasive fungal infections: a review of epidemiology and management options. J Med Microbiol 2006; 55: 809-18. [ Links ]

    7. Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolongued neutropenic patients and stem cell trasnplantation recipients: a prospective validation. Blood 2001; 97: 1604-10. [ Links ]

    8. Cruz R, Piontelli E. Enfermedad fúngica invasora (EFI) en pacientes de cinco hospitales de la quinta región de Valparaíso, Chile. 2004 a 2009. Rev Chil Infect 2011; 28 (2): 123-9. [ Links ]

    9. Carrasco E, Sepúlveda R, Rojas L, Mendéz P, Vicherat L, Otero M. Perfil clínico inmunológico de la aspergilosis broncopulmonar alérgica (ABPA). Enf Resp Cir Tórax 1998; 4: 76-82. [ Links ]

    10. Carrasco E. ABPA complicaciones poco usuales de la afección. Rev Chil Enf Respir 2004; 20: 30-6. [ Links ]

    11. Maggiolo J, Rubilar L, González R, Girardi G, Vildósola C, Mendoza C. Aspergilosis broncopulmonar alérgica en niños con enfermedad pulmonar crónica y fibrosis quística. Rev Chil Pediatr 2006; 77 (2): 161-8. [ Links ]

    12. Walzer P. Minireviews. Inmunological features of Pneumocystis carinii infection in humans. Clin Diagn Lab Immunol 1999; 6 (2): 149-55. [ Links ]

    13. Catherinot E, Lanternier F, Bougnoux M, Lecuit M, Couderc L, Lortholary O. Pneumocystis jirovecii Pneumonia. Infect Dis Clin North Am 2010; 24 (1): 107-38. [ Links ]

    14. Calderón E, Gutiérrez-Rivero S, Durand-Joly I, Dei-Cas E. Pneumocystis infection in humans: diagnosis and treatment. Expert Rev Anti Infect Ther 2010; 8 (6): 683-701. [ Links ]

    15. Bava A, Moreno D, Bellegarde E. Comparación de 3 técnicas para el diagnóstico de la neumocistosis pulmonar en pacientes con SIDA. Rev Argent Microbiol 2005; 37: 150-2. [ Links ]

    16. Casanova L, Cedillo R, Garduño G, Muñoz O. Comparación de dos tinciones en la detección de Pneumocystis carinii. Rev Invest Clin 1996; 48 (6): 443-7. [ Links ]

    17. Barbosa J, Bragada C, Costa de Oliveira S, Ricardo E, Rodrigues A, Pina-Vaz, C. A new method for the detection of Pneumocystis jirovecii using flow cytometry. Eur J Clin Microbiol Infect Dis 2010; 29: 1147-52. [ Links ]

    18. De Pauw B, Walsh TJ, Donnelly P, Stevens A, Edwards E, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-21. [ Links ]

    19. Kontoyiannis D, Marr K, Park B, Alexander B, Anaissie E, Walsh T, et al. Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001-2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 2010; 50: 1091-100. [ Links ]

    20. Mesa J, Rivas P, Cuervo S, Mejía M. Diagnóstico histopatológico de micosis invasivas en el paciente inmunocomprometido del Instituto Nacional de Cancerología, Bogotá. Rev Colomb Cancerol 2006; 10 (3): 207-11. [ Links ]

    21. Fica A. Infecciones en el paciente con trasplante de organos solidos. Rev Hosp Clin Univ Chile 2007; 18: 346-62. [ Links ]

    22. Lasso M. Diagnóstico y tratamiento de infecciones oportunistas en el paciente adulto con infección por VIH/ SIDA. Rev Chil Infect 2011; 28 (5): 440-60. [ Links ]

    23. Rabagliati R, Fuentes G, Guzmán AM, Orellana E, Oporto J, Aedo I, et al. Enfermedad fúngica invasora en pacientes hemato-oncológicos y receptores de trasplante de precursores hematopoyéticos bajo la perspectiva de los criterios diagnósticos EORTC/MSG. Rev Chil Infect 2009; 26 (3): 212-9. [ Links ]

    24. Retamal C, Díaz C, Salamanca L, Ferrada L, Álvarez de Oro R. Aspergilosis pulmonar en Chile. Enfoque inmunológico. Bol Micol 1984; 2 (1): 11-6. [ Links ]

    25. Zambrano A, Biere A, Isamitt D. Aspergilosis necrotizante crónica en un paciente con secuelas de tuberculosis pulmonar. Rev Chil Enf Respir 2007; 23: 43-8. [ Links ]

    26. Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K. Trends in the postmortem epidemiology of invasive fungal infections at a University Hospital. J Infect 1996; 33 (1): 23-32. [ Links ]

    27. Patterson T, Kirkpatrick R, White M, Hiemenz J, Wingard J, Dupont B, et al. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. Medicine (Baltimore) 2000; 79: 250-60. [ Links ]

    28. Cornely O, Maertens J, Winston D, Perfect J, Ullmann A, Walsh T, et al. Posaconazole vs Fluconazole or Itraconazole Prophylaxis in patients with neutropenia. N Engl J Med 2007; 356: 348-59. [ Links ]

    29. Cruz R, Barthel E, Piontelli E, Fernández G. Reportes clínicos: infección rinosinusal probada por Aspergillus flavus y probable infección pulmonar por Emericella nidulans en pacientes inmunodeprimidos. Bol Micol Vol 2005; 20: 109-15. [ Links ]

    30. Pemán J. ¿Qué se puede esperar del diagnóstico micológico clásico de la aspergilosis invasora?. Aspergilosis invasora. Guía de bolsillo. Editor: José Pontón 2003; 47-50. [ Links ]

    31. Del Palacio A, Cuétara M, Pontón J. La aspergilosis invasora. Rev Iberoam Micol 2003; 20: 77-8. [ Links ]

    32. Oxilia H, Oxilia R, Morales L, Falco F. Aspergilosis: una patología a considerar. Rev Argent Radiol 2008; 72 (1): 55-60. [ Links ]

    33. Procop G, Haddad S, Quinn M, Wilson M, Henshaw N, Reller L, et al. Detection of Pneumocystis jirovecii in respiratory specimens by tour staing methods. J Clin Microbiol 2004; 3333-5. [ Links ]

    34. Walter P. Minireviews. Inmunological features of Pneumocystis carinii infection in humans. Clin Diagn Lab Immunol 1999; 6 (2): 149-55. [ Links ]

    35. Raab S, Cheville J, Bottles K, Cohen M. Utility of Gomori methenamine silver stains in bronchoalveolar lavage specimens. Mod Pathol 1994; 7 (5): 599-604. [ Links ]

    36. Pinel C, Fricker-Hidalgo H, Lebeau B, Garban F, Hamidfar R, Ambroise-Thomas P, et al. Detection of circulating Aspergillus fumigatus Galactomannan: Value and Limits of the Platelia Test for Diagnosing Invasive Aspergillosis. J Clin Microbiol 2003; 41 (5): 2184-6. [ Links ]

    37. Ansorg R, van der Boom R, Rath PM. Detection of Aspergillus galactomannan antigen in foods and antibiotics. Mycoses 1997; 40: 353-7. [ Links ]

    38. Maertens J, Verhaegen J, Demuynck H, Brock P, Verhoef G, Vandenberghe P, et al. Autopsy-Controlled Prospective Evaluation of Serial Screening for Circulating Galactomannan by a Sandwich Enzyme-Linked Immunosorbent Assay for Hematological Patients at Risk for Invasive Aspergillosis. J Clin Microbiol 1999; 37(10): 3223-8. [ Links ]

    39. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, et al. Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 327-60. [ Links ]

    40. Lass-Flörl C. The changing face of epidemiology of invasive fungal disease in Europe. Mycoses 2009; 52 (3): 197-205. [ Links ]

    41. Taverner J, Maymó J, Carbonell J. Profilaxis anti-Pneumocystis jiroveci en pacientes reumáticos tratados con glucocorticoides. Semin Fund Esp Reumatol 2009; 10 (2): 53-5. [ Links ]

    42. Ward MM, Donald F. Pneumocystis carinii pneumonia in patients with connective tissue diseases. The role of hospital experience in diagnosis and mortality. Arthritis Rheum 1999; 42: 780-9. [ Links ]

    43. Charles T, Limper A. Pneumocystis Pneumonia. N Engl J Med 2004; 350: 2487-98. [ Links ]